Dr. Richard Kim, MD
Claim this profileMoffitt Cancer Center
Studies Pancreatic Cancer
Studies Colorectal Cancer
14 reported clinical trials
28 drugs studied
Area of expertise
1Pancreatic Cancer
Stage IV
Stage III
FGFR2 positive
2Colorectal Cancer
Stage IV
Affiliated Hospitals
Clinical Trials Richard Kim, MD is currently running
Enfortumab Vedotin
for Colorectal and Liver Cancers
This study is a multi-indication, open-label, single-treatment arm, parallel-cohort phase II study of enfortumab vedotin in adult participants with advanced or metastatic colorectal cancer (CRC) or hepatocellular carcinoma (HCC) who have been previously treated with one or more lines of systemic therapy.
Recruiting1 award Phase 23 criteria
Tele-Resistance Training
for Gastrointestinal Cancer
The purpose of the study is to evaluate a tele-resistance training exercise program for individuals undergoing chemotherapy for advanced upper gastrointestinal cancer.
Recruiting1 award Phase 1 & 2
More about Richard Kim, MD
Clinical Trial Related2 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Richard Kim, MD has experience with
- Pembrolizumab
- Regorafenib
- Glufosfamide
- Fluorouracil
- LSTA1
- SGN-EGFRd2
Breakdown of trials Richard Kim, MD has run
Pancreatic Cancer
Colorectal Cancer
Bile Duct Cancer
Liver Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Richard Kim, MD specialize in?
Richard Kim, MD focuses on Pancreatic Cancer and Colorectal Cancer. In particular, much of their work with Pancreatic Cancer has involved Stage IV patients, or patients who are Stage III.
Is Richard Kim, MD currently recruiting for clinical trials?
Yes, Richard Kim, MD is currently recruiting for 4 clinical trials in Tampa Florida. If you're interested in participating, you should apply.
Are there any treatments that Richard Kim, MD has studied deeply?
Yes, Richard Kim, MD has studied treatments such as Pembrolizumab, Regorafenib, Glufosfamide.
What is the best way to schedule an appointment with Richard Kim, MD?
Apply for one of the trials that Richard Kim, MD is conducting.
What is the office address of Richard Kim, MD?
The office of Richard Kim, MD is located at: Moffitt Cancer Center, Tampa, Florida 33612 United States. This is the address for their practice at the Moffitt Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.